These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16044005)

  • 21. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling the impact of modified directly observed antiretroviral therapy on HIV suppression and resistance, disease progression, and death.
    Kagay CR; Porco TC; Liechty CA; Charlebois E; Clark R; Guzman D; Moss AR; Bangsberg DR
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S414-20. PubMed ID: 15156432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The feasibility of a community-based directly administered antiretroviral therapy program.
    Wohl AR; Garland WH; Squires K; Witt M; Larsen R; Kovacs A; Hader S; Weidle PJ
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S388-92. PubMed ID: 15156427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of community- versus clinic-based adherence clubs on loss from care and viral suppression for antiretroviral therapy patients: Findings from a pragmatic randomized controlled trial in South Africa.
    Hanrahan CF; Schwartz SR; Mudavanhu M; West NS; Mutunga L; Keyser V; Bassett J; Van Rie A
    PLoS Med; 2019 May; 16(5):e1002808. PubMed ID: 31112543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients.
    Cantudo-Cuenca MR; Jiménez-Galán R; Almeida-Gonzalez CV; Morillo-Verdugo R
    J Manag Care Spec Pharm; 2014 Aug; 20(8):844-50. PubMed ID: 25062078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of a modified directly administered antiretroviral treatment intervention on virological outcome in HIV-infected patients treated in Burkina Faso and Mali.
    Pirkle CM; Boileau C; Nguyen VK; Machouf N; Ag-Aboubacrine S; Niamba PA; Drabo J; Koala S; Tremblay C; Rashed S
    HIV Med; 2009 Mar; 10(3):152-6. PubMed ID: 19245536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
    Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
    J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study.
    Hung CC; Chen MY; Hsieh SM; Hsiao CF; Sheng WH; Chang SC
    Vaccine; 2004 May; 22(15-16):2006-12. PubMed ID: 15121313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxyurea plus didanosine as maintenance therapy for HIV-infected patients on long-term successful highly active antiretroviral therapy.
    Barreiro P; de Mendoza C; Camino N; García-Benayas T; Blanco F; Núñez M; González-Lahoz J; Soriano V
    HIV Clin Trials; 2003; 4(6):361-71. PubMed ID: 14628279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Program increases HAART adherence in HIV patients.
    AIDS Alert; 1999 Mar; 14(3):31-2. PubMed ID: 11366214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonadherence with pediatric human immunodeficiency virus therapy as medical neglect.
    Roberts GM; Wheeler JG; Tucker NC; Hackler C; Young K; Maples HD; Darville T
    Pediatrics; 2004 Sep; 114(3):e346-53. PubMed ID: 15342896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary findings of an intervention integrating modified directly observed therapy and risk reduction counseling.
    Mitchell CG; Freels S; Creticos CM; Oltean A; Douglas R
    AIDS Care; 2007 Apr; 19(4):561-4. PubMed ID: 17453598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents.
    Eley B; Nuttall J; Davies MA; Smith L; Cowburn C; Buys H; Hussey G
    S Afr Med J; 2004 Aug; 94(8):643-6. PubMed ID: 15352588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short- and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: a randomized trial.
    Sarna A; Luchters S; Geibel S; Chersich MF; Munyao P; Kaai S; Mandaliya KN; Shikely KS; Temmerman M; Rutenberg N
    J Acquir Immune Defic Syndr; 2008 Aug; 48(5):611-9. PubMed ID: 18645509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender Differences in HIV Care among Criminal Justice-Involved Persons: Baseline Data from the CARE+ Corrections Study.
    Beckwith C; Castonguay BU; Trezza C; Bazerman L; Patrick R; Cates A; Olsen H; Kurth A; Liu T; Peterson J; Kuo I
    PLoS One; 2017; 12(1):e0169078. PubMed ID: 28081178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.
    Ammassari A; Murri R; Pezzotti P; Trotta MP; Ravasio L; De Longis P; Lo Caputo S; Narciso P; Pauluzzi S; Carosi G; Nappa S; Piano P; Izzo CM; Lichtner M; Rezza G; Monforte A; Ippolito G; d'Arminio Moroni M; Wu AW; Antinori A;
    J Acquir Immune Defic Syndr; 2001 Dec; 28(5):445-9. PubMed ID: 11744832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Directly observed antiretroviral therapy for injection drug users with HIV infection.
    Clarke S; Keenan E; Ryan M; Barry M; Mulcahy F
    AIDS Read; 2002 Jul; 12(7):305-7, 312-6. PubMed ID: 12161852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial.
    Gross R; Zheng L; La Rosa A; Sun X; Rosenkranz SL; Cardoso SW; Ssali F; Camp R; Godfrey C; Cohn SE; Robbins GK; Chisada A; Wallis CL; Reynolds NR; Lu D; Safren SA; Hosey L; Severe P; Collier AC;
    Lancet HIV; 2015 Jan; 2(1):e12-9. PubMed ID: 26424232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.